PCOS has a new name: What PMOS means and why it changed
A global consensus process has officially renamed polycystic ovary syndrome. Here's what changed, who decided it, and what it means if you or someone you know has the condition.
Polycystic ovary syndrome has a new name. Following a multi-year global consensus process published in The Lancet, the condition is now officially polyendocrine metabolic ovarian syndrome, or PMOS, a change that affects an estimated 170 million women worldwide.
This isn't a cosmetic rebrand. It's a correction to a name that implied a condition centered on ovarian cysts while obscuring the endocrine and metabolic dysfunction that drives most of what people actually experience.
Why the old name was a problem
The old name pointed to the wrong organ and the wrong pathology. "Polycystic" implied the ovaries were full of pathological cysts, but what typically shows up on ultrasound is a cluster of small, immature follicles that didn't ovulate that cycle, not cysts in the clinical sense.
The diagnostic criteria never lined up cleanly with the name, either. Under the Rotterdam criteria used since 2003, a diagnosis requires only two of three features: excess androgen levels, irregular ovulation, or polycystic-appearing ovaries. That means plenty of people are diagnosed with "polycystic ovary syndrome" without ever having polycystic ovaries, while others have that same ovarian appearance on ultrasound without having the syndrome at all.
Meanwhile, the name said nothing about what actually drives most of the condition's symptoms and long-term risk: insulin. Most people with the condition also have insulin resistance, and high insulin levels push the ovaries to overproduce androgens, which in turn worsens insulin resistance further, a two-way cycle rather than a one-time finding. That cycle, not ovarian cysts, is why the condition tracks with weight gain, acne, excess hair growth, and elevated long-term risk for type 2 diabetes and heart disease. A name built entirely around ovarian anatomy left that mechanism, and the metabolic risk that comes with it, essentially invisible. For more on how that insulin-androgen cycle works day to day, see our full guide to PCOS and metabolic health.
The 2026 Levels Guide to PMOS (PCOS) and metabolic health
PMOS (PCOS) is a condition affecting fertility, weight, and more—and it's intimately tied to metabolic health.
For patients, that mismatch translated into real delays. A longitudinal international survey of more than 22,000 patients and health professionals, conducted across six continents as part of the renaming effort, found that people consistently described the old name as confusing and disconnected from their actual symptoms, which in turn contributed to missed or delayed diagnoses and care that focused on ovarian symptoms while overlooking metabolic ones.
What PMOS stands for
The new name breaks into three deliberate parts, each chosen to correct a specific gap in the old one.
Polyendocrine signals that multiple hormone systems are involved, not just reproductive hormones. Androgens, insulin, and other endocrine signals all interact, rather than the ovaries acting alone.
Metabolic puts insulin resistance and metabolic dysfunction at the center of the condition, rather than treating them as a side effect. This is arguably the most consequential piece of the new name, since it formally recognizes insulin resistance as a driver of the condition rather than just a downstream complication.
Ovarian keeps the reproductive piece in the name, since ovulation and fertility are still affected, but it no longer stands alone as the whole story.
Together, the new name describes a condition where insulin resistance, androgen excess, and ovarian dysfunction interact and reinforce each other, with downstream effects on weight, skin, mental health, and long-term disease risk. That's a much closer match to the underlying biology than a name built around a single, often-absent ovarian finding.
How the change happened
This wasn't one institution updating its style guide. The renaming came out of a global consensus process that combined patient survey data, clinician workshops, and input from more than 56 patient organizations and medical societies worldwide.
Major professional bodies have already signed on. The Endocrine Society and the American Society for Reproductive Medicine both endorsed the new terminology, and pediatric endocrinology groups were represented too, since PCOS diagnoses have been rising fastest among adolescents, with girls aged 10 to 14 showing the steepest increase of any age group. Patients themselves were reportedly the biggest drivers of the change, having spent years describing a name that felt disconnected from their actual symptoms: irregular cycles, weight changes, acne, fatigue, and mood effects that a name about ovarian cysts never explained.
What it means for care
Nothing changes overnight for anyone currently diagnosed. The diagnostic criteria and first-line treatments, from combined hormonal contraceptives to metformin to lifestyle-based approaches, stay the same, and a chart that still says "PCOS" doesn't mean you've been misdiagnosed.
What the new name is meant to change is the shape of care going forward. A pediatric endocrinologist involved in the international effort has pointed to her own clinic's model, which pairs gynecology with nutrition and dermatology, as the kind of coordinated care the new name is meant to make standard rather than the exception. Under the old, ovary-centered name, insulin, glucose, and lipid panels were often treated as optional add-ons rather than core parts of a workup. The explicit inclusion of "metabolic" in the name gives clinicians and insurers less room to treat that testing as extra.
What diet is best for PMOS (PCOS)?
Eating a metabolically friendly diet can have a significant impact on PMOS (PCOS) symptoms. Here's what you need to know.
The name may also help close the diagnostic gap itself. Because the old name was so tightly tied to ovarian and cycle symptoms, people whose presentation leaned more metabolic (weight changes, acne, fatigue) without obvious cycle irregularity were more likely to be missed or bounced between specialists before landing on a diagnosis. A framework that treats the metabolic features as core, not incidental, gives clinicians another way in.
If you're managing the condition, the practical shift worth paying attention to is which parts of your care, reproductive or metabolic, are actually being monitored, since the new name argues both deserve equal footing. For more on how insulin resistance drives PCOS/PMOS symptoms and how tools like continuous glucose monitoring can help manage it, see our full guide to PCOS and metabolic health.
Take control of your health with expert guidance
Levels pairs real-time glucose data and comprehensive lab testing with clinician analysis and personalized support—everything you need to turn insights into real health improvements. Click here to get started with Levels.
